ISRCTN98241100已完成未知
Randomised trial of interstitial brachytherapy as a component of radical radiotherapy for localised prostatic carcinoma
HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 218 人开始时间: 2004年1月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 218
研究概览
简要总结
2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/22341794 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31059955 results (added 08/05/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •Patients with prostatic carcinoma who after routine staging have no evidence of distant metastasis. Patients will be male and over 40 years of age. In general external beam treatment is delivered as an outpatient whilst the interstitial treatment will require two to three days inpatient care.
排除标准
- •1. Prostate specific antigen (PSA) over 50
- •2. Previous Transurethral Resection of the Prostate (TURP)
- •3. Radiological evidence of distant metastasis
研究者
相似试验
已完成
不适用
SABRE 1: Surgery Against Brachytherapy - a Randomised EvaluatioMalignant neoplasm of prostateProstate cancerCancerISRCTN88144169Southampton University Hospitals NHS Trust (UK)400
终止
1 期
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerStage I Renal Cell CancerStage II Renal Cell CancerNCT04473781Jonsson Comprehensive Cancer Center2
已完成
不适用
Intraluminal brachytherapy treatment results analysis of unresectable recurrent cholangiocarcinomaNeoplasmsKCT0000738Chonbuk National University Hospital30
已完成
早期 1 期
Intraoperative Placement of Cesium-131 Permanent Interstitial Brachytherapy in Head and Neck CancerHead and Neck CancerHead and Neck Squamous Cell CarcinomaNCT02794675Case Comprehensive Cancer Center15
终止
2 期
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ColitisUlcerative ColitisIBDNCT03616821AstraZeneca242